The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012–2014

• Peibin Zeng,

  Affiliation West China School of Public Health, Sichuan University, Chengdu, Sichuan, China

  ⨯
• Yu Liu ,

  * E-mail: 21615620@qq.com (YL); messa1022@126.com (MH)

  Affiliation Institute of Blood Transfusion, Chinese Academic of Medical Science, Chengdu, Sichuan, China

  ⨯
• Miao He ,

  * E-mail: 21615620@qq.com (YL); messa1022@126.com (MH)

  Affiliation Institute of Blood Transfusion, Chinese Academic of Medical Science, Chengdu, Sichuan, China

  ⨯
• Jingxing Wang,

  Affiliation Institute of Blood Transfusion, Chinese Academic of Medical Science, Chengdu, Sichuan, China

  ⨯
• Sheila Keating,

  Affiliation Blood System Research Institute, San Francisco, California, United States of America

  ⨯
• Wei Mao,

  Affiliation Chongqing Blood Center, Chongqing, China

  ⨯
• Mei Huang,

  Affiliation Mianyang Blood Center, Mianyang, Sichuan, China

  ⨯
• Hongli Ma,

  Affiliation Louyang Blood Center, Luoyang, Henan, China

  ⨯
• Weilan He,

  Affiliation Guangxi Blood Center, Liuzhou, Guangxi, China

  ⨯
• Xinhong Bi,

  Affiliation Xinjiang Blood Center, Urumqi, Xinjiang, China

  ⨯
• Dan Liao,

  Affiliation Research Triangle Institute, Research Triangle Park, North Carolina, United States of America

  ⨯
• Michael Busch,

  Affiliation Blood System Research Institute, San Francisco, California, United States of America

  ⨯
• Paul Ness,

  Affiliation Department of Transfusion Medicine, Johns Hopkins Hospital, Baltimore, Maryland, United States of America

  ⨯
• Jing Liu,

  Affiliation Department of Transfusion Medicine, Johns Hopkins Hospital, Baltimore, Maryland, United States of America

  ⨯
• Hua Shan,

  Affiliation Department of Pathology, Stanford University, Palo Alto, California, United States of America

  ⨯
•  [ ... ],
• on behalf of the NHLBI Recipient Epidemiology and Donor Evaluation Study-III program

  ¶Membership of the NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) program is provided in the Acknowledgments.

  ⨯
• [ view all ]
• [ view less ]